Astera Labs, Inc. $ALAB Shares Purchased by Van ECK Associates Corp

Van ECK Associates Corp boosted its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 20.0% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,237,961 shares of the company’s stock after acquiring an additional 373,545 shares during the quarter. Astera Labs comprises 0.7% of Van ECK Associates Corp’s holdings, making the stock its 26th largest holding. Van ECK Associates Corp’s holdings in Astera Labs were worth $1,080,980,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in ALAB. BlackRock Inc. acquired a new position in shares of Astera Labs in the 2nd quarter valued at $6,609,581,000. Bank of America Corp DE acquired a new stake in shares of Astera Labs during the 2nd quarter worth about $1,061,791,000. Atreides Management LP increased its position in shares of Astera Labs by 108.9% during the 1st quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock worth $368,890,000 after purchasing an additional 1,754,593 shares during the last quarter. Amundi raised its holdings in Astera Labs by 1,298.6% in the 3rd quarter. Amundi now owns 1,421,263 shares of the company’s stock valued at $278,283,000 after buying an additional 1,319,643 shares during the period. Finally, Artisan Partners Limited Partnership purchased a new stake in Astera Labs in the 4th quarter valued at about $148,980,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Stock Performance

NASDAQ ALAB opened at $289.47 on Friday. The firm has a market cap of $50.22 billion, a price-to-earnings ratio of 143.30 and a beta of 3.84. The firm has a 50 day simple moving average of $342.38 and a 200-day simple moving average of $249.65. Astera Labs, Inc. has a one year low of $97.89 and a one year high of $499.48.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, topping the consensus estimate of $0.69 by $0.11. The firm had revenue of $392.40 million for the quarter, compared to the consensus estimate of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm’s revenue for the quarter was up 104.5% on a year-over-year basis. During the same period in the prior year, the firm earned $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Equities analysts predict that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

Analyst Ratings Changes

ALAB has been the subject of several research analyst reports. Susquehanna increased their target price on shares of Astera Labs from $230.00 to $275.00 and gave the stock a “neutral” rating in a research note on Friday, July 31st. Evercore reissued an “outperform” rating and issued a $297.00 price target on shares of Astera Labs in a research note on Tuesday, May 19th. Rothschild & Co Redburn assumed coverage on shares of Astera Labs in a report on Friday, May 1st. They issued a “neutral” rating and a $153.00 price objective on the stock. Roth Capital reaffirmed a “buy” rating and set a $450.00 price objective on shares of Astera Labs in a research report on Wednesday, August 5th. Finally, Zacks Research upgraded shares of Astera Labs from a “hold” rating to a “strong-buy” rating in a report on Tuesday, August 11th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and eight have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $340.53.

Insiders Place Their Bets

In other news, CEO Jitendra Mohan sold 90,630 shares of the stock in a transaction on Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the sale, the chief executive officer directly owned 1,266,665 shares in the company, valued at approximately $431,109,432.75. This trade represents a 6.68% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan A. Dyckerhoff sold 8,994 shares of Astera Labs stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $450.00, for a total value of $4,047,300.00. Following the completion of the transaction, the director owned 4,631 shares of the company’s stock, valued at approximately $2,083,950. This trade represents a 66.01% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 419,244 shares of company stock valued at $163,135,169. Corporate insiders own 10.40% of the company’s stock.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.